Torrent to acquire Unichem’s India, Nepal businesses for Rs 3,600 croreThe transaction is ongoing concern basis by way of slump sale, the company said in a statement to NSE.
- Buy Torrent Pharmaceuticals, target Rs 1570 : Edelweiss Financial Services
Buy Torrent Pharmaceuticals Ltd. at a price target of Rs 1570 and that target can be reached in a year.
Torrent Pharma gains post March quarter resultsThe company (excluding Zyg Pharama) had posted a net profit of Rs 130 crore in the corresponding quarter last year, the company said in a B...
TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are the Sensex and the Nifty are part of your daily life, and actions on Dalal Street can make or mar your...
Torrent Pharma board approves Zyg Pharma's amalgamationTorrent Pharmaceuticals today said its board has given nod to the scheme of amalgamation of its subsidiary Zyg Pharma with the company.
Sensex in red, gold at 5-year low, Novartis at lifetime high, Federal Bank slumps 9%The S&P BSE Sensex plunged over 100 points in trade on Monday ahead of earnings to be released later this week.
Eighteen stocks in focus in Monday's tradeIndian markets are expected to trade higher. Here is a list of eighteen stocks which are likely to remain in focus today.
Torrent Pharma completes Zyg Pharma acquisitionDrug firm Torrent Pharmaceuticals today said that it has completed acquisition of Encore Group firm Zyg Pharma Pvt Ltd.
Torrent Pharmaceuticals rallies on acquisition plansTorrent Pharma rose nearly 3% in trade on the BSE on Wednesday, following reports that the drug firm has inked an agreement
Torrent Pharma to acquire Zyg Pharma for an undisclosed sumThe acquisition will help the company strengthen its position in niche dermatological segment, especially in developed markets like the US ...